Skip to main navigation Skip to search Skip to main content

Suramin, an active nonhormonal cytotoxic drug for treatment of prostate cancer: Compelling reasons for testing in patients with hormone-refractory breast cancer

Research output: Contribution to journal › Editorial › peer-review

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalJournal of the National Cancer Institute
Volume84
Issue number1
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this